Filing metadata

Accession number
0001209191-20-036635
Form type
Form 3
Filer
CRISPR Therapeutics AG
CIK
CIK 1674416
Filed
Jun 15, 2020
Reporting period
Jun 11, 2020
Description
Initial ownership

Explore SEC Filings Hub